Quest Partners LLC Myriad Genetics Inc Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Quest Partners LLC holds 2,641 shares of MYGN stock, worth $36,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,641
Previous 8,001
66.99%
Holding current value
$36,392
Previous $219 Million
83.48%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$209 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$146 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$82.7 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$76.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$59.9 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.11B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...